Prime medicine to present at 41st annual j.p. morgan healthcare conference

Cambridge, mass., jan. 03, 2023 (globe newswire) -- prime medicine, inc. (nasdaq: prme), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced that keith gottesdiener, m.d., president and chief executive officer of prime medicine, will present a corporate overview at the 41st annual j.p. morgan healthcare conference on monday, january 9, 2023 at 8:15 a.m. pt (11:15 a.m. et) in san francisco, ca.
PRME Ratings Summary
PRME Quant Ranking